UK markets closed
NIKKEI 225
32,858.31 -587.59 (-1.76%) HANG SENG
16,345.89 -117.37 (-0.71%) CRUDE OIL
69.35 -0.03 (-0.04%) GOLD FUTURES
2,047.00 -0.90 (-0.04%) DOW
36,138.01 +83.58 (+0.23%) Bitcoin GBP
34,335.16 -596.80 (-1.71%)
NVO Jun 2024 57.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:05PM EST. Market open.
| Previous close | 0.3000 |
| Open | 0.3500 |
| Bid | 0.3000 |
| Ask | 0.5500 |
| Strike | 57.50 |
| Expiry date | 2024-06-21 |
| Day's range | 0.3000 - 0.3500 |
| Contract range | N/A |
| Volume | |
| Open interest | 72 |
ZacksIs It Worth Investing in Novo Nordisk (NVO) Based on Wall Street's Bullish Views?
According to the average brokerage recommendation (ABR), one should invest in Novo Nordisk (NVO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ZacksAbbVie (ABBV) to Acquire Cerevel Therapeutics (CERE) for $8.7B
AbbVie (ABBV) offers to buy Cerevel Therapeutics (CERE) for $8.7 billion. The acquisition will strengthen AbbVie's neuroscience pipeline.
ZacksJ&J (JNJ) Announces 2024 and Long-Term Financial Outlook
J&J (JNJ) expects operational sales growth in the range of 5-6% in 2024, driven by both its Innovative Medicine and MedTech divisions.
© 2023 Yahoo. All rights reserved.